Is a complete LYEL research report available?

No complete published report is available for Lyell Immunopharma, Inc. (LYEL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · USD

$10.9

+0.80 (+7.9%)· Recorded snapshot

Market cap	267.6M
Revenue (ttm)	27K
Net income (ttm)	-248.5M
EPS (ttm)	-$11.8
Shares out	24.5M
Volume	138,568
Beta	-0.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27K
Net income (ttm): -248.5M
EPS (ttm): -$11.8
Market cap: 267.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001806952
Company name	Lyell Immunopharma, Inc.
Country	United States
Country code	US
CUSIP number	55083R203
Earnings date	2026-11-11
Earnings time	amc
Employees	161
Employees change	-139
Employees growth	-46.33%
Enterprise value	$86.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-06-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US55083R2031
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2025-06-02
Last stock split type	Reverse
Market cap	$267.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$10.92
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LYEL
U.S. state	California
Website	https://www.lyell.com

Metric

Value

Amount currency

USD

CIK code

0001806952

Company name

Lyell Immunopharma, Inc.

Country

United States

Country code

CUSIP number

55083R203

Earnings date

2026-11-11

Earnings time

amc

Employees

161

Employees change

-139

Employees growth

-46.33%

Enterprise value

$86.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-06-17

Is primary listing

Yes

Is SPAC

ISIN number

US55083R2031

Last 10-K release date

2026-03-12

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2025-06-02

Last stock split type

Reverse

Market cap

$267.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$10.92

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LYEL

U.S. state

California

Website

https://www.lyell.com

Metric	Value
Earnings yield	-108.26%
EV/Sales	2,466.37x
FCF / EV yield	-201.18%
FCF yield	-54.02%
Forward EV/Sales	4,169.82x
Forward P/S	15,528.62x
P/B ratio	1.01x
P/S ratio	9,184.89x
Price / tangible book value	1.06x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-108.26%

EV/Sales

2,466.37x

FCF / EV yield

-201.18%

FCF yield

-54.02%

Forward EV/Sales

4,169.82x

Forward P/S

15,528.62x

P/B ratio

1.01x

P/S ratio

9,184.89x

Price / tangible book value

1.06x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-705,411.11%
Pretax margin	-920,285.19%
Profit per employee	$-1.5M
Revenue per employee	$168
ROA	-34.18%
ROA (5Y)	-18.9%
ROCE	-70.21%
ROE	-93.28%
ROE (5Y)	-47.15%
ROIC	-37.53%
SBC / revenue	146,770.37%

Metric

Value

Gross margin

100%

Operating margin

-705,411.11%

Pretax margin

-920,285.19%

Profit per employee

$-1.5M

Revenue per employee

$168

ROA

-34.18%

ROA (5Y)

-18.9%

ROCE

-70.21%

ROE

-93.28%

ROE (5Y)

-47.15%

ROIC

-37.53%

SBC / revenue

146,770.37%

Metric	Value
EPS growth quarters	6
EPS growth years	1
Gross profit growth	-55%
Gross profit growth (Q)	-50%
Gross profit growth 3Y	-91.77%
Gross profit growth 5Y	-68.32%
Net income growth years	1
Revenue growth	-55%
Revenue growth (Q)	-50%
Revenue growth (QoQ)	100%
Revenue growth 3Y	-91.77%
Revenue growth 5Y	-68.32%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-55%

Gross profit growth (Q)

-50%

Gross profit growth 3Y

-91.77%

Gross profit growth 5Y

-68.32%

Net income growth years

Revenue growth

-55%

Revenue growth (Q)

-50%

Revenue growth (QoQ)

100%

Revenue growth 3Y

-91.77%

Revenue growth 5Y

-68.32%

Revenue growth years

Metric	Value
Capital expenditures	$-711,000
Depreciation and amortization	$9.5M
EBIT	$-190.5M
EBITDA	$-180.9M
EPS	$-11.82
FCF per share	$-5.47
Financing cash flow	$102.5M
Free cash flow	$-134M
Free cash flow minus SBC	$-173.6M
Gross profit	$27,000
Investing cash flow	$5M
Net cash flow	$-25.8M
Net income	$-248.5M
Operating cash flow minus SBC	$-172.9M
Operating income	$-190.5M
Revenue	$27,000
Stock-based compensation	$39.6M

Metric

Value

Capital expenditures

$-711,000

Depreciation and amortization

$9.5M

EBIT

$-190.5M

EBITDA

$-180.9M

EPS

$-11.82

FCF per share

$-5.47

Financing cash flow

$102.5M

Free cash flow

$-134M

Free cash flow minus SBC

$-173.6M

Gross profit

$27,000

Investing cash flow

$5M

Net cash flow

$-25.8M

Net income

$-248.5M

Operating cash flow minus SBC

$-172.9M

Operating income

$-190.5M

Revenue

$27,000

Stock-based compensation

$39.6M

Metric	Value
Altman Z-Score	-5.88
Book value per share	$9.99
Debt / equity	0.2
Long-term assets	$97.6M
Long-term liabilities	$37.5M
Net cash (debt)	$181.4M
Net cash / market cap	73.15%
Net cash growth	-24.96%
Net debt / equity	-0.78
Piotroski F-Score	1
Property, plant and equipment	$47.3M
Shareholders' equity	$233.8M
Tangible book value	$233.8M
Tangible book value per share	$9.99
Total assets	$311.2M
Total cash	$204.1M
Total debt	$46.6M
Total liabilities	$77.3M
WACC	3.42%

Metric

Value

Altman Z-Score

-5.88

Book value per share

$9.99

Debt / equity

0.2

Long-term assets

$97.6M

Long-term liabilities

$37.5M

Net cash (debt)

$181.4M

Net cash / market cap

73.15%

Net cash growth

-24.96%

Net debt / equity

-0.78

Piotroski F-Score

Property, plant and equipment

$47.3M

Shareholders' equity

$233.8M

Tangible book value

$233.8M

Tangible book value per share

$9.99

Total assets

$311.2M

Total cash

$204.1M

Total debt

$46.6M

Total liabilities

$77.3M

WACC

3.42%

Metric	Value
Asset turnover	0
Current assets	$213.5M
Current liabilities	$39.9M
Current ratio	5.36
Net working capital	$-20.8M
Quick ratio	5.12
Working capital	$173.7M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$213.5M

Current liabilities

$39.9M

Current ratio

5.36

Net working capital

$-20.8M

Quick ratio

5.12

Working capital

$173.7M

Working capital turnover

Metric	Value
Buyback yield / dilution	-49.16%
Dividend yield	0%
Shareholder yield	-49.16%

Metric

Value

Buyback yield / dilution

-49.16%

Dividend yield

Shareholder yield

-49.16%

Metric	Value
150-day SMA	$14.88
1D price change	7.91%
1M price change	9.44%
1M total return	9.44%
1W price change	11.13%
1W total return	11.13%
1Y price change	-37.43%
1Y return CAGR	-37.45%
1Y total return	-37.43%
20-day SMA	$8.97
200-day SMA	$16.99
3M price change	-16.82%
3M total return	-16.82%
3Y price change	-65.67%
3Y return CAGR	-29.97%
3Y total return	-65.67%
50-day SMA	$11.20
50-day SMA vs 200-day SMA	50under200
52-week high	$45.00
52-week high date	2025-12-22
52-week low	$7.20
52-week low date	2026-10-14
5Y price change	-96.25%
5Y return CAGR	-48.15%
5Y total return	-96.25%
6M price change	-52.34%
6M total return	-52.34%
All-time high	$396.80
All-time high date	2021-09-07
All-time low	$7.20
All-time low date	2026-10-14
Average true range (ATR)	$0.73
Average volume	158.3K
Beta (1Y)	2.07
Beta (2Y)	1.76
Beta (5Y)	-0.03
Change from 52-week high	-75.73%
Change from 52-week low	51.77%
Change from all-time high	-97.28%
Change from all-time low	49.83%
Change from open	8.87%
Day's gap	-0.89%
Dollar volume	$1.5M
High price	$10.92
Low price	$10.03
Monthly RSI	36.4
Open price	$10.03
Position in 52-week range	100%
Previous close	$10.12
Price vs 150-day SMA	-27.56%
Price vs 20-day SMA	20.19%
Price vs 200-day SMA	-36.56%
Price vs 50-day SMA	-3.72%
Relative volume	0.88
Return from IPO open	-97.3%
Return from IPO price	-40.47%
RSI	60.94
Sharpe ratio	-0.24
Sharpe ratio (3Y)	0.09
Sharpe ratio (5Y)	-0.27
Sortino ratio	-0.28
Sortino ratio (3Y)	0.2
Sortino ratio (5Y)	-0.34
Volume	138.6K
Weekly RSI	41.93
YTD price change	-64.98%
YTD total return	-64.98%

Metric

Value

150-day SMA

$14.88

1D price change

7.91%

1M price change

9.44%

1M total return

9.44%

1W price change

11.13%

1W total return

11.13%

1Y price change

-37.43%

1Y return CAGR

-37.45%

1Y total return

-37.43%

20-day SMA

$8.97

200-day SMA

$16.99

3M price change

-16.82%

3M total return

-16.82%

3Y price change

-65.67%

3Y return CAGR

-29.97%

3Y total return

-65.67%

50-day SMA

$11.20

50-day SMA vs 200-day SMA

50under200

52-week high

$45.00

52-week high date

2025-12-22

52-week low

$7.20

52-week low date

2026-10-14

5Y price change

-96.25%

5Y return CAGR

-48.15%

5Y total return

-96.25%

6M price change

-52.34%

6M total return

-52.34%

All-time high

$396.80

All-time high date

2021-09-07

All-time low

$7.20

All-time low date

2026-10-14

Average true range (ATR)

$0.73

Average volume

158.3K

Beta (1Y)

2.07

Beta (2Y)

1.76

Beta (5Y)

-0.03

Change from 52-week high

-75.73%

Change from 52-week low

51.77%

Change from all-time high

-97.28%

Change from all-time low

49.83%

Change from open

8.87%

Day's gap

-0.89%

Dollar volume

$1.5M

High price

$10.92

Low price

$10.03

Monthly RSI

36.4

Open price

$10.03

Position in 52-week range

100%

Previous close

$10.12

Price vs 150-day SMA

-27.56%

Price vs 20-day SMA

20.19%

Price vs 200-day SMA

-36.56%

Price vs 50-day SMA

-3.72%

Relative volume

0.88

Return from IPO open

-97.3%

Return from IPO price

-40.47%

RSI

60.94

Sharpe ratio

-0.24

Sharpe ratio (3Y)

0.09

Sharpe ratio (5Y)

-0.27

Sortino ratio

-0.28

Sortino ratio (3Y)

0.2

Sortino ratio (5Y)

-0.34

Volume

138.6K

Weekly RSI

41.93

YTD price change

-64.98%

YTD total return

-64.98%

Metric	Value
Float	12.1M
Float percentage	49.52%
Shares change (QoQ)	6.8%
Shares change (YoY)	49.16%
Shares held by insiders	7.26%
Shares held by institutions	36.58%
Shares outstanding	24.5M
Short % of float	10.41%
Short % of shares	5.16%
Short ratio	9.4 days

Metric

Value

Float

12.1M

Float percentage

49.52%

Shares change (QoQ)

6.8%

Shares change (YoY)

49.16%

Shares held by insiders

7.26%

Shares held by institutions

36.58%

Shares outstanding

24.5M

Short % of float

10.41%

Short % of shares

5.16%

Short ratio

9.4 days

Lyell Immunopharma, Inc. (LYEL)

Price

Financial snapshot

Fair-value bridge

Latest news · LYEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LYEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LYEL

Frequently asked questions